Please use this identifier to cite or link to this item:
|Title:||Development of potential antiviral strategy against coxsackievirus B4||Authors:||Tan, E.L.
Potential antiviral strategy
RNA interference (RNAi)
Type 1 insulin dependent diabetes mellitus (IDDM)
|Issue Date:||2010||Citation:||Tan, E.L., Wong, A.P.Y., Poh, C.L. (2010). Development of potential antiviral strategy against coxsackievirus B4. Virus Research 150 (1-2) : 85-92. ScholarBank@NUS Repository. https://doi.org/10.1016/j.virusres.2010.02.017||Abstract:||Coxsackievirus B4 (CVB4) can cause a broad range of diseases such as aseptic meningitis, meningoencephalitis, myocarditis, hepatitis, pancreatitis, gastroenteritis, necrotizing enterocolitis, pneumonia and sudden death in the neonates. CVB4 has also been implicated as a possible etiological agent for type 1 insulin dependent diabetes mellitus (IDDM). In this study, the possibility of RNA interference (RNAi) as a potential therapeutic approach to treat CVB4 infection was explored. The results showed that the Rhabdomyosarcoma (RD) cells treated with 19-mer siRNAs displayed high specificity against CVB4 replication without displaying any sign of target effects. The siRNA targeting the 3Cpro region of CVB4 genome was also established to be the most effective in inhibition of CVB4 replication in RD cell line in a dosage dependent manner, indicating its potential to be developed as an antiviral strategy against CVB4. © 2010 Elsevier B.V.||Source Title:||Virus Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/25624||ISSN:||01681702||DOI:||10.1016/j.virusres.2010.02.017|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 17, 2020
WEB OF SCIENCETM
checked on Jan 10, 2020
checked on Dec 31, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.